The Patent Finder

Raven Biotechnologies, Inc.

Also on record
Records under this name other than patents Raven Biotechnologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Raven Biotechnologies, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,527,969Novel RAAG10 Cell Surface Target and a Family of Antibodies Recognizing That Target
Formerly held
Term ended
Term ended Oct 7, 2025 · High confidence
Term endedTerm ended Oct 7, 2025High confidence
US 8,779,098Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
Formerly held
Term ended
Term ended Aug 11, 2024 · High confidence
Term endedTerm ended Aug 11, 2024High confidence
US 9,574,007Novel B7-H3L Cell Surface Antigen and Antibodies That Bind Thereto
Formerly held
Term ended
Term ended Sep 9, 2023 · High confidence
Term endedTerm ended Sep 9, 2023High confidence
US 7,718,774TES7 and antibodies that bind thereto
Formerly held
Lapsed on the fee record
Ended May 18, 2022 · USPTO record
Lapsed on the fee recordEnded May 18, 2022USPTO record
US 7,674,619ADAM-9 modulators
Formerly held
Lapsed on the fee record
Ended Mar 9, 2022 · USPTO record
Lapsed on the fee recordEnded Mar 9, 2022USPTO record
US 7,572,895Transferrin receptor antibodies
Formerly held
Lapsed on the fee record
Ended Aug 11, 2021 · USPTO record
Lapsed on the fee recordEnded Aug 11, 2021USPTO record
US 7,569,672Antibodies that bind to EphA2 and methods of use thereof
Formerly held
Lapsed on the fee record
Ended Aug 4, 2021 · USPTO record
Lapsed on the fee recordEnded Aug 4, 2021USPTO record
US 7,078,231Human pancreatic epithelial progenitor cells and methods of isolation and use thereof
Formerly held
Term ended
Term ended Feb 5, 2021 · USPTO record
Term endedTerm ended Feb 5, 2021USPTO record
US 8,361,475ADAM-9 modulators
Formerly held
Lapsed on the fee record
Ended Jan 29, 2021 · USPTO record
Lapsed on the fee recordEnded Jan 29, 2021USPTO record
US 8,309,354Human cancer stem cells
Formerly held
Lapsed on the fee record
Ended Nov 13, 2020 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2020USPTO record
10 of 30 patents shown.
Pro members see all 30.
Pro members: see all 30 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited